Cencora (BSP:C1CO34) EV-to-Revenue

: 0.19 (As of Today)

View and export this data going back to 2020. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cencora's enterprise value is R$261,461 Mil. Cencora's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was R$1,349,875 Mil. Therefore, Cencora's EV-to-Revenue for today is 0.19.

The historical rank and industry rank for Cencora's EV-to-Revenue or its related term are showing as below:

BSP:C1CO34' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.09 Med: 0.15 Max: 0.21
Current: 0.18

During the past 13 years, the highest EV-to-Revenue of Cencora was 0.21. The lowest was 0.09. And the median was 0.15.

BSP:C1CO34's EV-to-Revenue is ranked better than
84.69% of 98 companies
in the Medical Distribution industry
Industry Median: 0.595 vs BSP:C1CO34: 0.18

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-19), Cencora's stock price is R$629.00. Cencora's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was R$3,317.89. Therefore, Cencora's PS Ratio for today is 0.19.

Cencora EV-to-Revenue Historical Data

The historical data trend for Cencora's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EV-to-Revenue

0.10

0.14

0.13

0.15

Cencora Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue																0.16	0.15	0.17	0.15	0.16

Competitive Comparison

For the Medical Distribution subindustry, Cencora's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cencora EV-to-Revenue Distribution

For the Medical Distribution industry and Healthcare sector, Cencora's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cencora's EV-to-Revenue falls into.

Cencora EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cencora's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	261461.080	/	1349875.208
	=	0.19

Cencora's current Enterprise Value is R$261,461 Mil.
Cencora's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$1,349,875 Mil.

Cencora (BSP:C1CO34) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cencora's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	629.00	/	3317.888
	=	0.19

Cencora's share price for today is R$629.00.
Cencora's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$3,317.89.

Cencora EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cencora's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cencora (BSP:C1CO34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (BSP:C1CO34) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

COR:USA ABG:Germany ABG:Germany ABC:Austria

Address

1 West First Avenue, Conshohocken, PA, USA, 19428-1800

Website

https://www.cencora.com

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora (BSP:C1CO34) Headlines

No Headlines